StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Equities research analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a note issued to investors on Tuesday. The firm set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and set a $1.25 price objective on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Trading Up 2.0 %

Shares of MLSS stock opened at $1.02 on Tuesday. The company’s fifty day simple moving average is $0.83 and its 200-day simple moving average is $0.84. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.10. The company has a market cap of $79.45 million, a PE ratio of -14.57 and a beta of 1.08.

Insider Buying and Selling at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the sale, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold 109,193 shares of company stock valued at $101,634 over the last 90 days. 24.75% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Milestone Scientific

A number of hedge funds have recently bought and sold shares of the business. World Investment Advisors LLC acquired a new position in shares of Milestone Scientific in the 3rd quarter valued at approximately $91,000. Geode Capital Management LLC raised its holdings in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in Milestone Scientific during the 3rd quarter valued at $48,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.